C12N 2760/18171
Demonstrated in vivo effect
C12N2760/18171 (Demonstrated in vivo effect) appears on 28 US grants and 41 published applications in this corpus.
Search patents in C12N- Granted patents
- 28
- Published applications
- 41
- Assignees
- 20
- Inventors
- 65
- Latest grant
- 31 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 1 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 2 |
| 2010 | 0 | 1 |
| 2011 | 0 | 1 |
| 2012 | 0 | 2 |
| 2013 | 1 | 1 |
| 2014 | 1 | 5 |
| 2015 | 5 | 1 |
| 2016 | 2 | 4 |
| 2017 | 3 | 3 |
| 2018 | 1 | 2 |
| 2019 | 5 | 2 |
| 2020 | 1 | 3 |
| 2021 | 1 | 3 |
| 2022 | 1 | 5 |
| 2023 | 1 | 3 |
| 2024 | 2 | 2 |
| 2025 | 1 | 0 |
| 2026 | 2 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Multivalent HVT vector vaccine31 Mar 2026US 12,589,147 B2Intervet Inc.
- Recombinant herpesvirus of turkeys (HVT) and preparation method and use thereof6 Jan 2026US 12,516,353 B2Yangzhou University
- Methods for immunizing pre-immune subjects against respiratory syncytial virus (RSV)14 Oct 2025US 12,440,552 B2University of Massachusetts
- Extended-range spray applicator12 Mar 2024US 11,925,951 B2Boehringer Ingelheim Animal Health USA Inc.
- Oncolytic virus for colorectal cancer treatment using colorectal cancer cell-specific infectious newcastle disease virus and composition for colorectal cancer treatment using same30 Jan 2024US 11,884,931 B2Libentech Co., Ltd.
- Newcastle Disease Virus with Improved Heat Resistance, and Newcastle Disease Virus Vaccine Comprising Same5 Mar 2026US 2026/0061047 A1Biopoa, Inc.
- Extended-range spray applicator6 Jun 2024US 2024/0181477 A1Boehringer Ingelheim Animal Health USA Inc.
- Methods for immunizing pre-immune subjects against respiratory syncytial virus (rsv)14 Mar 2024US 2024/0082386 A1University of Massachusetts
- Recombinant herpesvirus of turkeys (hvt) and preparation method and use thereof11 May 2023US 2023/0147673 A1Yangzhou University
- Oncolytic virus for colorectal cancer treatment using colorectal cancer cell-specific infectious newcastle disease virus and composition for colorectal cancer treatment using same20 Apr 2023US 2023/0121063 A1Libentech Co., Ltd.
Most cited
By later US patents
- Chimeric Newcastle disease viruses and uses thereof10US 8,591,881 B2Memorial Sloan Kettering Cancer Center · 2013
- Live vaccines and methods of treatment therewith9US 6,506,385 B1Embrex, Inc. · 2003
- Chimeric viruses presenting non-native surface proteins and uses thereof8US 9,387,242 B2Icahn School of Medicine at Mount Sinai · 2016
- Virus-like particles as vaccines for paramyxovirus7US 8,974,797 B2University of Massachusetts · 2015
- Chimeric Newcastle disease viruses and uses thereof7US 9,217,136 B2Icahn School of Medicine at Mount Sinai · 2015